JPMorgan Downgrades Boston Scientific (BSX) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq slides over 1% as Alphabet results revive AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $41.90 -1.25%
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 22 | New: 16
Rating Summary:
29 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 22 | New: 16
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus downgraded Boston Scientific (NYSE: BSX) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
Shares of Boston Scientific closed at $45.06 yesterday.
You May Also Be Interested In
- Oppenheimer Downgrades Boston Scientific (BSX) to Perform
- KeyBanc Downgrades Alkami Technology Inc (ALKT) to Sector Weight
- Boston Scientific (BSX) PT Raised to $51 at Baird
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
